How Much Does GLP-1 Medication Actually Cost in 2026 — With and Without Insurance

If you've been curious about GLP-1 medications like Ozempic or Wegovy but assumed you couldn't afford them — you're not alone. Cost is the number one reason people hesitate. But the landscape has changed dramatically in 2026, and most people are surprised to learn how accessible these medications have become.

Here's the honest, full breakdown of what GLP-1 treatment actually costs right now.

The brand-name price — and why most people don't pay it

Brand-name GLP-1 medications like Wegovy and Ozempic can cost between $900 and $1,349 per month at retail without insurance. That number stops a lot of people in their tracks — and understandably so.

But here's what most people don't know: very few people actually pay retail price.

With insurance

Coverage for GLP-1 medications varies widely by insurance plan. Medicare historically did not cover GLP-1s for weight loss, but as of July 1, 2026, CMS launched the GLP-1 Bridge program — making eligible Medicare beneficiaries able to access certain GLP-1 medications for as little as $50 per month through the end of 2027.

Private insurance coverage depends entirely on your specific plan. Some plans cover GLP-1s for diabetes treatment but not for weight loss specifically. The only way to know for sure is to call your insurance provider and ask directly.

Without insurance — the cash-pay options

This is where things get interesting. The rise of telehealth and compounded GLP-1 medications has completely changed the affordability equation.

Compounded semaglutide — a pharmacy-made version of the active ingredient in Ozempic and Wegovy — is widely available through telehealth providers at a fraction of the brand-name cost. Many people are accessing GLP-1 treatment for $99 to $400 per month through cash-pay telehealth platforms, no insurance required.

Oral GLP-1 options have also entered the market in 2026. The newly FDA-approved Orforglipron is available at $149 per month for all doses, and oral Wegovy launched at $199 per month — making the barrier to entry lower than ever before.

What affects your out-of-pocket cost?

Several factors influence what you'll actually pay:

The type of medication — brand-name versus compounded versus oral options vary significantly in price.

The provider you use — telehealth platforms with cash-pay models are almost always more affordable than traditional in-person clinics billing through insurance.

Your dosage — most GLP-1 medications are started at a low dose and titrated up over time. Your cost may increase slightly as your dose increases.

Your location — some states have different pharmacy regulations that affect availability and pricing of compounded options.

Is cheaper always worse?

Not at all. Compounded semaglutide contains the same active ingredient as brand-name Wegovy and Ozempic. The difference is that it is prepared by a licensed compounding pharmacy rather than manufactured by a pharmaceutical company. When sourced through a legitimate telehealth provider using an FDA-registered compounding pharmacy, compounded semaglutide is considered safe and effective.

The key is going through a licensed provider — not buying from unregulated online sources that don't require a prescription.

So what will it actually cost you?

The honest answer is: it depends on your situation. But for most people using a telehealth platform without insurance, a realistic monthly cost is somewhere between $99 and $350 per month depending on the medication type and dosage.

The only way to know exactly what options are available to you and at what price is to complete a free assessment with a licensed provider.

The bottom line

GLP-1 treatment is more affordable in 2026 than it has ever been. Brand-name sticker prices are not what most people actually pay. Telehealth has opened up cash-pay options that make this treatment accessible to everyday Americans — not just people with great insurance or high incomes.

If cost has been the thing holding you back, it might be worth finding out what your actual options are.

America is Well is not a medical provider. We connect individuals with trusted, licensed, independent healthcare providers. This article is for informational purposes only and is not a substitute for professional medical advice.